Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
10.5 NOK | 0.00% | +6.60% | 0.00% |
Mar. 01 | Arctic Bioscience AS Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Mar. 01 | Transcript : Arctic Bioscience AS, Q4 2023 Earnings Call, Mar 01, 2024 |
Sales 2024 * | 57M 5.24M | Sales 2025 * | 79M 7.26M | Capitalization | 266M 24.5M |
---|---|---|---|---|---|
Net income 2024 * | -30M -2.76M | Net income 2025 * | -50M -4.6M | EV / Sales 2024 * | 1.92 x |
Net cash position 2024 * | 157M 14.44M | Net cash position 2025 * | 106M 9.75M | EV / Sales 2025 * | 2.03 x |
P/E ratio 2024 * |
-8.73
x | P/E ratio 2025 * |
-5.27
x | Employees | 17 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 38.42% |
Latest transcript on Arctic Bioscience
1 week | +6.60% | ||
Current month | +7.14% | ||
3 months | +3.96% | ||
6 months | +26.51% |
Managers | Title | Age | Since |
---|---|---|---|
Hogne Hallaråker
FOU | Founder | 58 | 10-12-31 |
Chief Executive Officer | 52 | 22-02-28 | |
Jone R. Slinning
DFI | Director of Finance/CFO | 45 | 22-03-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 44 | 20-12-31 | |
Director/Board Member | 55 | 19-12-31 | |
Harald Nordal
FOU | Founder | 66 | 10-12-31 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-03 | 10.5 | 0.00% | 1,021 |
24-05-02 | 10.5 | +7.14% | 1,000 |
24-04-30 | 9.8 | 0.00% | 0 |
24-04-29 | 9.8 | -0.51% | 5,500 |
24-04-26 | 9.85 | 0.00% | 0 |
Real-time Oslo Bors, May 03, 2024 at 10:45 am EDT
More quotesEPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
0.00% | 24.57M | |
+21.85% | 546B | |
-4.77% | 359B | |
+16.97% | 323B | |
+5.69% | 290B | |
+13.68% | 234B | |
+3.65% | 198B | |
-11.12% | 194B | |
+8.08% | 167B | |
-3.40% | 157B |
- Stock Market
- Equities
- ABS Stock